Perceptive Informatics® Global Survey Results Indicate Growing Demand for CTMS to Assist in More Efficient Site Monitoring and Management

BOSTON, May 19, 2011 /PRNewswire/ — Perceptive
Informatics, the industry’s leading eClinical solutions
provider and a subsidiary of PAREXEL International Corporation
(NASDAQ:
PRXL), today announced results of a global survey conducted
during its webinar entitled “Critical Tasks of Site Monitors: Using
a CTMS to Improve Efficiency.” Perceptive polled
biopharmaceutical industry professionals across a broad range of
clinical, data management and IT functions about the value of
providing Clinical Research Associates (CRAs) with access to a Clinical Trial
Management System (CTMS) to assist in site monitoring and
management activities during clinical trials.

The survey results revealed that 89% of respondents provide CRAs
with access to either a CTMS or other monitoring tool. The majority
of these respondents combine other monitoring tools with a CTMS to
achieve greater site monitoring and management efficiencies. A CTMS
helps CRAs to view the status of a clinical trial, access patient
data, and identify outstanding issues, as well as to make informed
decisions about requirements for site visits. The remaining
respondents (11%) provide no access to these types of systems.

“As site management is a key part of the CRA role, providing
CRAs with access to the cross-study and cross-site data available
within a CTMS is vital. There is growing recognition across the
industry that when CRAs use sophisticated eClinical technologies
they are more efficient in site monitoring and management
activities,” said Liz Love, Product Manager of CTMS, Perceptive
Informatics. “At Perceptive, we are focused on enabling more
effective centralized and field-based monitoring through our CTMS
to support an increasingly mobile and globalized CRA
workforce.”

The IMPA

‘/>”/>

SOURCE